SCHEMBL20677208

SCHEMBL20677208

NC(=O)OCCOCCOCCOCCOCCNC(=O)CCCCCN1C(=O)C=CC1=O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTT P42858 3/20 0.47
▸ SMN1; SMN2 Q16637 3/20 0.47
▸ HPGD P15428 2/20 0.47
▸ PTGS1 P23219 7/20 0.46
▸ PTGS2 P35354 7/20 0.46
▸ MGLL Q99685 5/20 0.41
▸ ALDH1A1 P00352 5/20 0.41
▸ FAAH O00519 3/20 0.41
▸ HSP90AA1 P07900 1/20 0.41
▸ TLR9 Q9NR96 1/20 0.41
▸ LMNA P02545 1/20 0.41
▸ TP53 P04637 1/20 0.41
▸ MAPT P10636 1/20 0.41
▸ PKM P14618 1/20 0.41
▸ XBP1 P17861 1/20 0.41
▸ MAPK1 P28482 1/20 0.41
▸ RECQL P46063 1/20 0.41
▸ RAB9A P51151 1/20 0.41
▸ NPSR1 Q6W5P4 1/20 0.41
▸ GPR35 Q9HC97 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28630111 0.93 SMN1; SMN2 (0.51) HTTSMN1; SMN2HPGDPTGS1PTGS2
SCHEMBL31694371 0.89 HTT (0.48) HTTSMN1; SMN2HPGDPTGS1PTGS2
SCHEMBL22910736 0.89 PTGS1 (0.49) HTTSMN1; SMN2HPGDPTGS1PTGS2
SCHEMBL17841853 0.88 HTT (0.49) HTTSMN1; SMN2HPGDPTGS1PTGS2
SCHEMBL16107013 0.88 SMN1; SMN2 (0.49) HTTSMN1; SMN2HPGDPTGS1PTGS2
SCHEMBL17841851 0.88 HTT (0.49) HTTSMN1; SMN2HPGDPTGS1PTGS2
SCHEMBL24686272 0.86 HPGD (0.63) HTTSMN1; SMN2HPGDPTGS1PTGS2
SCHEMBL24687409 0.86 HPGD (0.63) HTTSMN1; SMN2HPGDPTGS1PTGS2
SCHEMBL24686939 0.86 HPGD (0.63) HTTSMN1; SMN2HPGDPTGS1PTGS2
SCHEMBL24686941 0.86 HPGD (0.63) HTTSMN1; SMN2HPGDPTGS1PTGS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3432934-A1 PRODRUGS OF CYTOTOXIC ACTIVE AGENTS HAVING ENZYMATICALLY CLEAVABLE GROUPS Bayer Pharma Aktiengesellschaft (DE) 2019-01-30 — — EP disclosed
Send feedback